Skip to main content

Inspection visit

Inspection

QUINCY HEALTHCARE & SR LIVINGCMS #1454572 citations on this visit
2 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 2 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0755 Level of Harm - Minimal harm or potential for actual harm Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. Based on observation, interview and record review the Facility failed to safely dispense medications to three of four Residents (R2, R3 and R4) reviewed for medication administration in a sample of four. Residents Affected - Few Findings include: Facility Administering Oral Medications Policy, undated, documents: the purpose of this procedure is to provide guidelines for the safe administration of oral medications; and remain with the Resident until all medications have been taken. 1. R2's Physician Order Sheet, dated 4/27/24, document R2's diagnoses including: Parkinsonism, Congestive Heart Failure, Muscle Weakness, Hypertension, Cerebrovascular Disease, Tremor, Dementia, Chronic Obstructive Pulmonary Disease, Centilobular Emphysema, Chronic Kidney Disease Stage Three, Peripheral Vascular Disease, Major Depressive Disorder an Anxiety. R2's Medication Administration Record, dated 4/27/24 at 8:00 am, documents that R2 was administered scheduled 8:00 am medication (Atenolol 50 milligram/mg tablet, Torsemide 10 mg tablet, Senna Lax 8.6 mg tablet, Aspirin 81 mg chewable tablet, Carbidopa 10 mg/Levadopa 100 mg tablet, Gabapentin 100 mg tablet, Acetaminophen Extened Release 650 mg tablet, Losartan 100 mg tablet, Folic Acid 1 mg tablet, Cyanocobalamin 100 microgram/mcg tablet and Pantoprazole 40 mg tablet). On 4/27/24 at 9:15 am, 9:40 am, and 10:01 am, R2 was laying in bed sleeping. A medication cup that contained Atenolol 50 milligram/mg tablet, Torsemide 10 mg tablet, Senna Lax 8.6 mg tablet, Aspirin 81 mg chewable tablet, Carbidopa 10 mg/Levadopa 100 mg tablet, Gabapentin 100 mg tablet, Acetaminophen Extened Release 650 mg tablet, Losartan 100 mg tablet, Folic Acid 1 mg tablet, Cyanocobalamin 100 microgram/mcg tablet and Pantoprazole 40 mg tablet was on R2's beside table. On 4/27/24 at 10:40 am, V7 (Licensed Practical Nurse) stated, I just put (R2's) 8:00 am medications in her room and she takes them after she wakes up and eats breakfast. I probably should not be doing that. 2. R3's Physician Order Sheet/POS, dated 4/27/24, document R2's diagnoses including: Sepsis, Cellulitis of Lower Limb, Pressure Ulcer Left Heel, Osteoarthritis, Diabetes Mellitus, Hypertension, Atrial Fibrillation, Transient Cerebral Ischemic Attack, Morbid Obesity, Bronchitis and Chronic Kidney Disease. R3's POS documents a medication order for Polyethylene Glycol Powder at 8:00 am. On 4/27/24 at 9:35 am, V7 (Licensed Practical Nurse) delivered R3's 8:00 am medications and V7 left (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 4 Event ID: 145457 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145457 B. Wing A. Building (X3) DATE SURVEY COMPLETED 04/29/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Quincy Healthcare & Sr Living 1440 North 10th Street Quincy, IL 62301 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few R3's medication (Polyethylene Glycol Powder/Metamucil) in a cup at R3's bedside. R3 stated, Just leave my medicine here and I will take it when I am done eating. V7 then left the medicine and walked out of R3's room. On 4/27/24 at 10:40 am, V7 (Licensed Practical Nurse) stated, I am just going to leave that with him (R3), he is just going to drink that after he finishes his breakfast. 3. R4's Physician Order Sheet/POS, dated 4/27/24, document R4's diagnoses including: Chronic Obstructive Pulmonary Disease, Hypertensive Heart Disease with Heart Failure, Heart failure, Protein-Calorie Malnutrition, Anorexia, Emphysema, Severe Hypertension, Palpitations, Major Depressive Disorder, Osteoarthritis, Anemia, Hypothyroidism, Hyperlipidemia, Urgency of Urination; Hypokalemia, Macular Degeneration and Dry Eye Syndrome. R4's POS also documents medication orders for Symbicort 160 mcg-4.5 mcg/actuation aerosol inhaler inhale two puffs by inhalation route two times per day at 8:00 am, Complete Multivitamin-Multimineral 18 milligram/mg-400 microgram/mcg tablet, give 1 tablet by oral route once daily with food every day at 8:00 am, Spiriva with HandiHaler 18 mcg and inhalation capsules inhale the contents of one capsule (18 mcg) using two inhalations by inhalation route once daily via handihaler every day at 8:00 am, Ascorbic Acid (Vitamin C) 500 mg tablet give 1 tablet by oral route once daily at 8:00 am, Ferrous Sulfate 325 mg (65 mg iron) tablet give one tablet (325 mg) by oral route once daily with breakfast at 8:00 am, Docusate Sodium 100 mg capsule give one capsule (100 mg) by oral route two times per day as needed, PreserVision one mg capsule give by oral route at 8:00 am, Cholecalciferol (Vitamin D3) 50 mcg (2,000 unit) tablet give one tablet by oral route at 8:00 am, Metoprolol Succinate Extended Release 25 mg 24 hour give one tablet (25 mg) by oral route once daily at 8:00 am, Citalopram 40 mg tablet give one tablet (40 mg) by oral route once daily at 8:00 am. On 4/27/24 at 9:10 am, 10:01 am and 11:50 am, a plastic medication cup that contained tablets/capsules and three inhalation medications (Spiriva, Albuterol and Symbicort) were on R4's bedside table. On 4/27/24 at 11:50 am, R4 stated, I was going to take those medications after I ate my breakfast. R4 stated, I think that cup has some iron, potassium, eye medicine and my anti-depressant, I am not really sure what else is in there. They usually just leave them sitting there (on the bedside table) for me to take when I am done eating. On 4/27/24 at 11:50 am, V3 (Licensed Practical Nurse) stated, I cannot believe that (R4) did not take her pills or inhalers yet. She usually takes them with her breakfast. I know it is probably not a good idea to leave them in (R4's) room. That medicine cup had Metoprolol, Eye Vitar, Vitamin C, Ducosate Sodium, Mutlivitamin and Citalopram in it and those inhalers are Symbicort and Spiriva. (R4) also likes to keep her rescue inhaler by her at all times also because she gets anxious. On 4/27/24 at 12:00 pm, V2 (Director of Nursing) stated, The nurses should not be leaving medicine in the rooms without watching the Residents take them, they should be staying with the Residents until they take them. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145457 If continuation sheet Page 2 of 4 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145457 B. Wing A. Building (X3) DATE SURVEY COMPLETED 04/29/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Quincy Healthcare & Sr Living 1440 North 10th Street Quincy, IL 62301 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760 Ensure that residents are free from significant medication errors. Level of Harm - Minimal harm or potential for actual harm Based on observation, interview, and record review the Facility failed to timely administer medications as ordered by the Physician for one (R3) of four Residents reviewed for Medication Administration in a sample of four. Residents Affected - Few Findings include: Facility Administering Oral Medications (Version 1.2), undated, documents: purpose is to provide guidelines for the safe administration of oral medications; verify that there is physician's medication order for this procedure; follow the medication guidelines in the policy; use Medication Administration Record; check the label on the medication and confirm name and dose with the Medication Administration Record; make sure all documentation is completed in a timely manner; responsible for administering all medications following the policies and standards of practice; monitor and assist in developing safety measures to provide a safe environment at all times; and promote safe practices at all times. R3's Physician Order Sheet/POS, dated 4/27/24, document R2's diagnoses including: Sepsis, Cellulitis of Lower Limb, Pressure Ulcer Left Heel, Osteoarthritis, Diabetes Mellitus, Hypertension, Atrial Fibrillation, Transient Cerebral Ischemic Attack, Morbid Obesity, Bronchitis and Chronic Kidney Disease. R3's POS documents Physician Orders for Humalog KwikPen sliding scale at 7:00 am. The POS also documents Physician Orders for 8:00 am medications (Allopurinol 100 milligram/mg two times a day, Carvedilol 25 mg tablet daily, Farxiga 5 mg tablet daily, Hydrocodone 5mg/Acetaminophen 325 mg two times a day, Losartan 50 mg daily, Pregabalin 150 mg two times a day, Ranexa 500 mg every twelve hours, Vitamin D3 25 micrograms/mcg daily, Acidophilus capsule daily, Psyllium Husk 2.6 mg moral powder daily, Lidocain Pain Relief Patch on at 8:00 am and off at 8:00 pm, Multivitamin daily, Lantus Solostart Insulin 40 units once daily, Humalog KwikPen 15 units daily, Levaquin 500 mg daily and Polyethlene Glycol 17 gram powder daily. Facility Medication Administration Times, undated, documents medication pass times at 5:00 am, 8:00 am, 12:00 pm, 5:00 pm and 8:00 pm. On 4/27/24 at 9:13 am, R3's breakfast tray was delivered and at 9:35 am, R3 had completed the breakfast meal. R3 stated I am almost done, I just cannot eat as much as I used to before I went to the hospital. On 4/27/24 at 9:35 am, V7 (Licensed Practical Nurse) prepared and administered R3's scheduled 7:00 am medications (Humalog KwikPen sliding scale) and 8:00 am medications (Allopurinol 100 milligram/mg two times a day, Carvedilol 25 mg tablet daily, Farxiga 5 mg tablet daily, Hydrocodone 5mg/Acetaminophen 325 mg two times a day, Losartan 50 mg daily, Pregabalin 150 mg two times a day, Ranexa 500 mg every twelve hours, Vitamin D3 25 micrograms/mcg daily, Acidophilus capsule daily, Psyllium Husk 2.6 mg moral powder daily, Lidocain Pain Relief Patch on at 8:00 am and off at 8:00 pm, Multivitamin daily, Lantus Solostart Insulin 40 units once daily, Humalog KwikPen 15 units daily, Levaquin 500 mg daily and Polyethlene Glycol 17 gram powder daily). On 4/27/24 at 9:35 am, V7 (Licensed Practical Nurse) stated, (R3) just got back from the Hospital a day or so ago and is still on an antibiotic (Levaquin) for an infection and (R3) also takes a lot of insulin, (R3) will be getting four extra units of Humalog for his blood sugar (Accucheck) for his sliding scale. V7 verified that R3 received medication, including insulin, after the scheduled (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145457 If continuation sheet Page 3 of 4 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145457 B. Wing A. Building (X3) DATE SURVEY COMPLETED 04/29/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Quincy Healthcare & Sr Living 1440 North 10th Street Quincy, IL 62301 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760 Physician ordered times and received insulin after R3 had finished the breakfast meal. Level of Harm - Minimal harm or potential for actual harm On 4/27/24 at 12:00 pm, V2 (Director of Nursing) stated, They should be getting their medicine at their scheduled times, especially insulin, that should not normally be given after a meal. Residents Affected - Few FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145457 If continuation sheet Page 4 of 4

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

2 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0755GeneralS&S Dpotential for harm

    F755 - Pharmacy Services

    Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.

  • 0760GeneralS&S Dpotential for harm

    F760 - Residents are free of any significant medication errors

    Ensure that residents are free from significant medication errors.

FAQ · About this visit

Common questions about this visit

What happened during the April 29, 2024 survey of QUINCY HEALTHCARE & SR LIVING?

This was a inspection survey of QUINCY HEALTHCARE & SR LIVING on April 29, 2024. The surveyor cited 2 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at QUINCY HEALTHCARE & SR LIVING on April 29, 2024?

Yes, 2 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharm..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.